Chronic Disease Consulting Diabetes Events 
Today's Hospitalist
JUNE 7, 2025
THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. Published in May 2024, the FLOW trial , for instance, looked at patients with diabetes and advanced kidney disease.
GeriPal
AUGUST 1, 2024
So if you already have a condition, you might be able to prevent events. But at any age, like, as Emily said, it is so important to pay attention to nutrition and healthy eating because it’s not just about, oh, chronic disease prevention or even treatment and management. And you can work at different levels of prevention.
Expert insights. Personalized for you.
63 
Let's personalize your content